BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

2:08 PM
 | 
Sep 15, 2017
 |  BC Week In Review  |  Company News  |  Deals

Allergan partners with tribe to fight IPR

In an effort to create a shield against patent challenges under the U.S. Patent and Trademark Office’s inter partes review process, Allergan plc (NYSE:AGN) announced Sept. 8 that it had transferred ownership of six patents covering dry eye drug Restasis cyclosporine to the Saint Regis Mohawk Tribe. Citing its sovereign immunity as a recognized tribal government, the tribe is filing a motion to dismiss ongoing IPR challenges to the patents, Allergan reported.

Allergan said its action is intended to eliminate the IPR...

Read the full 395 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >